Karyopharm Therapeutics, Inc. (KPTI)
0.3508
+0.04
(+11.37%)
USD |
NASDAQ |
Oct 15, 16:00
0.3483
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Cash from Operations (TTM) : -65.35M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -65.35M |
| March 31, 2026 | -59.11M |
| December 31, 2025 | -75.37M |
| September 30, 2025 | -89.35M |
| June 30, 2025 | -102.94M |
| March 31, 2025 | -122.74M |
| December 31, 2024 | -127.49M |
| September 30, 2024 | -120.26M |
| June 30, 2024 | -130.34M |
| March 31, 2024 | -117.54M |
| December 31, 2023 | -92.72M |
| September 30, 2023 | -100.98M |
| June 30, 2023 | -99.82M |
| March 31, 2023 | -109.27M |
| December 31, 2022 | -149.55M |
| September 30, 2022 | -97.24M |
| June 30, 2022 | -92.82M |
| March 31, 2022 | -113.42M |
| December 31, 2021 | -107.12M |
| September 30, 2021 | -163.22M |
| June 30, 2021 | -183.58M |
| March 31, 2021 | -168.11M |
| December 31, 2020 | -160.23M |
| September 30, 2020 | -169.09M |
| June 30, 2020 | -161.28M |
| Date | Value |
|---|---|
| March 31, 2020 | -169.21M |
| December 31, 2019 | -190.82M |
| September 30, 2019 | -199.50M |
| June 30, 2019 | -201.66M |
| March 31, 2019 | -191.09M |
| December 31, 2018 | -159.12M |
| September 30, 2018 | -116.48M |
| June 30, 2018 | -99.57M |
| March 31, 2018 | -83.66M |
| December 31, 2017 | -73.72M |
| September 30, 2017 | -88.18M |
| June 30, 2017 | -86.76M |
| March 31, 2017 | -85.93M |
| December 31, 2016 | -84.39M |
| September 30, 2016 | -84.77M |
| June 30, 2016 | -89.76M |
| March 31, 2016 | -96.97M |
| December 31, 2015 | -94.03M |
| September 30, 2015 | -86.42M |
| June 30, 2015 | -77.32M |
| March 31, 2015 | -61.10M |
| December 31, 2014 | -51.45M |
| September 30, 2014 | -48.76M |
| June 30, 2014 | -41.43M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -197.72M |
| Relay Therapeutics, Inc. | -212.20M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |